Electromed Inc. (ELMD)
Electromed Inc. (ELMD) Stock Price, Analysis & Data
| Bid | 41.36 |
| Market Cap | 347.02M |
| Revenue (ttm) | 71.75M |
| Net Income (ttm) | 10.1M |
| Beta | 0.51 |
| EPS (ttm) | 1.17 |
| PE Ratio (ttm) | 35.82 |
| Forward PE | 68.7 |
| P/B (ttm) | 7.06 |
| P/S (ttm) | 4.84 |
| Earnings Date | Aug 25, 2026 |
| Ask | 41.76 |
| Volume | 21,953 |
| Avg. Volume (20D) | 96,159 |
| Open | 42.37 |
| Previous Close | 42.39 |
| Day's Range | 41.60 - 42.85 |
| 52-Week Range | 18.81 - 47.40 |
| Analyst | n/a |
| Price Target | 40 (-4.56%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ELMD
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral pa...
Financial Performance
In 2025, Electromed's revenue was 64M, an increase of 16.97% compared to the previous year's 54.72M. Earnings were 7.54M, an increase of 46.35%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for ELMD stock is "null". The 12-month stock price forecast is 40, which is downside of 4.56% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
